The GPL-MycoTOX is a comprehensive mycotoxin test that screens for eleven mycotoxins and forty species of mould from a single urine sample.
Mycotoxins (toxins from mould) are some of the most prevalent toxins in the environment. Mycotoxins are metabolites produced by fungi like mould, which can infest buildings, vehicles, and foodstuffs. Most mycotoxin exposures in North America, Europe, and Australia are through airborne exposure. Food may be a major source of mycotoxins in third-world nations that lack government inspection of foods, especially the grains such as rice, corn, wheat, rye, and barley. Many grains that are harvested have been found to be contaminated with mycotoxins but little of such harvests are discarded and are frequently sold for animal feeds such as dog food or feed for cows, pigs, chickens, turkeys, and horses.
Fungi can grow on almost any surface, especially if the environment is warm and wet. Inner wall materials of buildings, wallpaper, fibre glass insulation, ceiling tiles, and gypsum support are all good surfaces for fungi to colonise. These fungi then release mycotoxins into the environment causing symptoms of many different chronic diseases. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. With the MycoTOX Profile, GPL says that you can identify mycotoxin exposures and make recommendations for detoxification treatments that have been effective.
Mycotoxins are measured using state-of-the-art liquid chromatography-mass spectrometry (LC-MS/MS) technology. Using this technology, they have a very sensitive test, which is important because mycotoxins can cause serious health issues even in small quantities.
This mycotoxin test is corrected for differences in fluid intake using the technique called creatinine correction. Failure to use creatinine correction can lead to a thirty-fold variation in the concentration of the mycotoxins when there is variation in fluid intake. Utilization of LC-MS/MS technology gives us a precise identification of all our analytes, which prevents having false-positive errors. For many of their compounds they can detect amounts in the parts per trillion (ppt) which is about 100-fold better than any other test currently available.
Aflatoxin M1 (AFM1)
Ochratoxin A (OTA)
Dihdrocitrinone Citrinin (DHC)
When should I use
Neurological conditions such autism, Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. Diseases and symptoms linked to mycotoxin exposure include fever, pneumonia-like symptoms, heart disease, rheumatic disease, asthma, sinusitis, nose bleeding, cancer, memory loss, vision loss, chronic fatigue, skin rashes, depression, ADHD, anxiety, and liver damage. A study of patients with chronic fatigue found that all the patients had high levels of mycotoxins in the urine.
GPL01 ENVIROtox Complete Panel is a cost-effective option to consider which includes OAT, Mycotoxins, GPL-Tox and Glyphosate.
We understand that there is some discussion and no real agreement regarding challenging with glutathione before urine mycotoxin testing. We don’t recommend this however it is a clinical decision that you may make for yourself.
However, Robyn Puglia, Clinical Support Specialist, suggests considering the following collection schedule to encourage mobilisation and elimination of toxins via urine:
The evening before the sample collection, immediately before going to bed:
First, empty the bladder, then perform full body dry body brushing followed by a hot bath with 4 cups of Epsom salts.
Then collect any urine passed from the time of getting out of the bath during the night and the first-morning void and create the sample out of the total urine collected.